Boehringer Ingelheim And Zhejiang Hisoar Pharmaceutical Sign Production Alliance
This article was originally published in PharmAsia News
Executive Summary
Boehringer Ingelheim and Zhejiang Hisoar Pharmaceutical have signed a strategic production alliance. Under the agreement, Hisoar will invest in a specialized workshop at its new plant in Chuannan and is scheduled to manufacture contract products for BI from 2009. The latter on its part will provide expertise and technology support for Hisoar. Listed on the Shenzhen bourse in 2006, Hisoar specializes in producing and selling pharmaceutical chemicals, active pharmaceutical ingredients and generic drugs. It has established GMP and EHS systems according to international standards. The firm said that the BI collaboration will boost its market position and influence, as well as give it a major leg-up toward globalization